Advanced Epithelial Ovarian Cancer

Patients with advanced epithelial ovarian cancer (EOC) should be treated with ... tumour angiogenesis, tyrosine kinase inhibitors, review. ... central...

0 downloads 0 Views 80KB Size

Recommend Documents

differences in prognosis. In order to address these issues, we report our experience regarding treatment and prognosis in elderly patients with. FIGO stages ...

Apr 4, 2016 - epithelial ovarian cancer is surgical staging followed by adjuvant ... The behavior of fallopian tube and primary peritoneal car- cinomas is ...

DI regimens remain investigational. ○ GOG 97. – Cisplatin/Cytoxan. – 4 vs. 8 cycles, equivalent dose .... Poor performance status. – Medical comorbidities.

Ovarian cancer is usually radiosensitive. Whole abdominal (WAR). – Microscopic disease. – 2500-3000 cGy over 4-5 weeks. Tumoricidal dose. – > 2cm.

Ovarian neoplasms consist of several histopathologic entities, and treatment depends on the specific tumor type. Epithelial ovarian cancer comprises most ma-.

Oct 11, 2012 - non-seromucinous EOC, non-epithelial ovarian tumors and primary peritoneal tumors were not included in the study. All patients underwent ...

Chen, V.W., Ruiz, B., Killeen, J.L., Coté, T.R., Wu, X.C., and Correa, C.N. (2003) ...... Faleiro-Rodrigues, C., Macedo-Pinto, I., Pereira, D., and Lopes, C.S. (2004) Loss of .... Evangelista,M., Tian, H., and de Sauvage F.J. (2006) The hedgehog ...

Xiaoxi Sun,3 Youji Feng,1 Viktor Janzen,4 and Tong Chen2. 1Department of Gynecology, Obstetrics and ...... Wei X, et al. (2010) Mullerian inhibiting substance.

Nov 9, 2010 - epithelial ovarian cancers (EOC). ... cells in human tumours came from a study in acute myeloid leukemia ...... of Biological Chemistry, vol. 275 ...

Dec 28, 2012 - The promise of personalized medicine is rapidly becoming a reality for the treatment of .... the AGO-Ovar/AIO and EBMT. J Clin Oncol 2007 ...

Mar 15, 1997 - Our 10-year experience with cisplatinum- based polychemotherapy in 196 advanced ovarian cancer patients previously untreated with.

University of Michigan, Ann Arbor, MI; Sheba Medical Center, Tel Hashomer, Israel; Assaf. Harofeh Medcl Ctr, Zerifin, Israel; Stanford University School of Medicine, ..... LLC), M Gordon (Pinnacle Oncology Hematology), N Haas (University.

Apr 15, 2013 - marine-derived alkaloid trabectedin (Yondelis), the combination regimen resulted in improved. PFS.[25]. Single-agent chemotherapy beyond ...

and the other four used pazopanib, nintedanib, cediranib, and trebananib. Bevacizumab has gained European Medicines. Agency approval for the first-line ...

Feb 15, 2013 - Keywords: Ovarian cancer, Brain metastases, Leptomeningeal disease, ... of cancer death in women and the leading cause of gynecologic can-.

Nov 27, 2017 - Paulette Mhawech-Fauceglia4, Heidi Sowter5, Dennis J. Hazelett2,**, Kate ...... Adler E, Mhawech-Fauceglia P, Gayther SA, Lawrenson.

well as peak gonadotropin stimulation. Postmenopausally, the. Cramer–Welch model relates .... term ''age at menopause/interview,'' which for the case subjects was essentially the same as age at diagnosis, ...... twins, no excess of ovarian cancer c

nificant difference in ovarian cancer risk between the 2 groups.11. Furthermore, 2 .... time spent in 3 intensity activity was categorized into the following ... Specific questions on physical activity are provided in the ... monal status and family

Feb 23, 2010 - Angiogenesis is essential for normal ovarian physiological ... Antiangiogenic therapies inhibit new blood vessel growth, induce ..... Common toxicities observed include fatigue, skin rash and GI toxicities, Table 4. .... need for biops

Feb 24, 2016 - Full-text PDF: ... Although surgery and platinum-based chemotherapy currently ... measured by using a microplate reader set at 570 nm. ... [ISI Journals Master List] [Index Medicus/MEDLINE] [EMBASE/Excerpta Medica].

Sep 13, 2015 - However, advanced stage clear cell carcinoma of ovary has a worse .... 3. While the incidence of serous carcinoma was highest among patients.

Jun 14, 2012 - that high NuMA levels at mitotic spindle poles were significantly associated with .... metaphase defects such as tripolar and multipolar spindles.

1 Department of Obstetrics and Gynecology, Falu Hospital, Falun, Sweden. 2 Department of Medical Epidemiology, Karolinska Institute, Stockholm, Sweden.

Such technologies can complement well-established clinical histopathology analysis ... ciated with serous tubal intraepithelial carcinoma as a precursor ..... (A) Flowchart of the study outlining the steps for training and validating the prognostic.